Back to trial details

Intake questionnaire

Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects

Applying to Nebraska Medicine - University of Nebraska Medical Center · Omaha, Nebraska

Answer a few short questions to share with the research team.

0 of 4 answered

1. Are you between 18 and 100 years old?
2. Have you been diagnosed with Breast Cancer?
3. Are you currently pregnant or breastfeeding?
4. Are you able to travel to Omaha for study visits?